on Biophytis (EPA:ALBPS)
Biophytis and LynxKite Feature at NVIDIA GTC Conference
Biophytis SA and LynxKite Technologies participated in the NVIDIA GTC conference, a prominent event in artificial intelligence and accelerated computing. Held from March 16 to 19, 2026, this gathering attracted over 25,000 attendees and featured 1,000 sessions led by tech leaders and global companies.
The conference showcased AI advancements, including updates to the AlphaFold Database and the unveiling of Proteina-Complexa. Biophytis, collaborating with LynxKite and Nebius, presented its AI-driven platform aimed at boosting drug discovery in the longevity market, valued at $1.5 trillion.
Biophytis also engaged with investors and partners, and demonstrated BIO101, their lead drug candidate. CEO Stanislas Veillet highlighted the company's commitment to leveraging AI for innovations in longevity.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Biophytis news